{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:43:08Z","timestamp":1794584588628,"version":"4.9.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.atherosclerosis.2026.120836","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:50:50Z","timestamp":1782345050000},"page":"120836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-study"],"prefix":"10.1016","volume":"419","author":[{"given":"Pruthvi C.","family":"Revaiah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya","family":"Vengrenyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vemuri Krishna","family":"Santosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Karki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Yasumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushal","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishani","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Sweeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil","family":"Khera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Hooda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro R.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagat","family":"Narula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samin K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7189-3307","authenticated-orcid":false,"given":"Annapoorna S.","family":"Kini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2026.120836_bib1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/CIRCINTERVENTIONS.114.001360","article-title":"Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the harmonizing outcomes with revascularization and stents in acute myocardial infarction trial","volume":"7","author":"Stone","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007174","article-title":"Culprit and nonculprit recurrent ischemic events in patients with myocardial infarction: data from SWEDEHEART (Swedish web System for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies)","volume":"7","author":"Varenhorst","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib4","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(21)00249-X","article-title":"Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study","volume":"397","author":"Erlinge","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib5","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jama.291.9.1071","article-title":"Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial","volume":"291","author":"Nissen","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib6","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.295.13.jpc60002","article-title":"Effect of very high-intensity Statin therapy on regression of coronary AtherosclerosisThe ASTEROID trial","volume":"295","author":"Nissen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib7","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1110874","article-title":"Effect of two intensive Statin regimens on progression of coronary disease","volume":"365","author":"Nicholls","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jacc.2015.05.065","article-title":"Impact of dual lipid-lowering strategy with ezetimibe and atorvastatin on coronary plaque regression in patients with percutaneous coronary intervention: the multicenter randomized controlled PRECISE-IVUS trial","volume":"66","author":"Tsujita","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib9","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2016.16951","article-title":"Effect of evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trial","volume":"316","author":"Nicholls","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib10","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/jama.2022.5218","article-title":"Effect of alirocumab added to high-intensity Statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: the PACMAN-AMI randomized clinical trial","volume":"327","author":"R\u00e4ber","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib11","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jcmg.2022.03.002","article-title":"Effect of evolocumab on coronary plaque phenotype and burden in statin-treated patients following myocardial infarction","volume":"15","author":"Nicholls","year":"2022","journal-title":"JACC, Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jamacardio.2023.2731","article-title":"Atherosclerotic coronary plaque regression and risk of adverse cardiovascular events: a systematic review and updated meta-regression analysis","volume":"8","author":"Iatan","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib13","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/jamacardio.2021.3055","article-title":"Association of statin treatment with progression of coronary atherosclerotic plaque composition","volume":"6","author":"van Rosendael","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib14","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/jamacardio.2019.5315","article-title":"Association of high-density calcified 1K plaque with risk of acute coronary syndrome","volume":"5","author":"van Rosendael","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib15","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jacc.2015.01.036","article-title":"Impact of statins on serial coronary calcification during atheroma progression and regression","volume":"65","author":"Puri","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib16","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/ehjci\/jet251","article-title":"Long-term effects of maximally intensive Statin therapy on changes in coronary atheroma composition: insights from SATURN","volume":"15","author":"Puri","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib17","doi-asserted-by":"crossref","first-page":"734","DOI":"10.4244\/EIJV12I6A118","article-title":"Integrated biomarker and imaging study 3 (IBIS-3) to assess the ability of rosuvastatin to decrease necrotic core in coronary arteries","volume":"12","author":"Oemrawsingh","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib18","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/eurheartj\/ehu373","article-title":"Effect of high-intensity Statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study","volume":"36","author":"R\u00e4ber","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4244\/EIJ-D-20-01355","article-title":"Artificial intelligence and optical coherence tomography for the automatic characterisation of human atherosclerotic plaques","volume":"17","author":"Chu","year":"2021","journal-title":"EuroIntervention"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4244\/EIJ-D-19-00182","article-title":"Diagnostic accuracy of intracoronary optical coherence tomography-derived fractional flow reserve for assessment of coronary stenosis severity","volume":"15","author":"Yu","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib21","doi-asserted-by":"crossref","first-page":"568","DOI":"10.4244\/EIJ-D-19-01034","article-title":"Diagnostic performance of intracoronary optical coherence tomography-based versus angiography-based fractional flow reserve for the evaluation of coronary lesions","volume":"16","author":"Huang","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib22","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jcmg.2025.12.013","article-title":"Intracoronary imaging and transcriptomic characteristics before and after maximum lipid-lowering therapy: YELLOW-III study of evolocumab and maximum statin therapy in chronic coronary disease","volume":"19","author":"Kini","year":"2026","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib23","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.4244\/EIJ-D-22-01098","article-title":"Diagnostic accuracy of optical flow ratio: an individual patient-data meta-analysis","volume":"19","author":"Hu","year":"2023","journal-title":"EuroIntervention"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.5603\/CJ.a2020.0071","article-title":"Diagnostic accuracy and reproducibility of optical flow ratio for functional evaluation of coronary stenosis in a prospective series","volume":"27","author":"Guti\u00e9rrez-Chico","year":"2020","journal-title":"Cardiol J"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib25","article-title":"First-in-Human experience with a novel multimodality DeepOCT-NIRS intracoronary imaging system","volume":"3","author":"Ali","year":"2024","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib26","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2026.120836_bib27","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026002029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026002029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:58:43Z","timestamp":1790107123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026002029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":27,"alternative-id":["S0021915026002029"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120836","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-study","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120836"}}